Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXR6XQ
|
||||
| Drug Name |
benzyl (S)-1-((S)-4-(benzylthio)-3-oxo-1-phenylbutan-2-ylamino)-1-oxo-3-phenylpropan-2-ylcarbamate
|
||||
| Synonyms |
CHEMBL321988
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C34H34N2O4S
|
||||
| Canonical SMILES |
O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)CSCc3ccccc3)OCc4ccccc4
|
||||
| InChI |
InChI=1S/C34H34N2O4S/c37-32(25-41-24-29-19-11-4-12-20-29)30(21-26-13-5-1-6-14-26)35-33(38)31(22-27-15-7-2-8-16-27)36-34(39)40-23-28-17-9-3-10-18-28/h1-20,30-31H,21-25H2,(H,35,38)(H,36,39)/t30-,31-/m0/s1
|
||||
| InChIKey |
VEPUZFAOTNXDNN-CONSDPRKSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.